![(R)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid structure, CAS 137862-87-4](/structures/80000/73779_1_137862_87_4.png)
CAS Number137862-87-4
Synonyms(R)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid; N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine; Valsartan,D; D-Valsartan; N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}valine; N-Pentanoyl-N-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-D-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine; DSSTox_CID_3735
Molecular FormulaC24H29N5O3
Molecular Weight435.52
Purity98%
Density1.2±0.1 g/cm3
Boiling Point684.9±65.0 °C at 760 mmHg
Melting Point108-110°C
Appearancesolid
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 137862-87-4 |
| Catalog No. | 2A-9073779 |
| Chinese Name | D-缬沙坦 |
| Synonyms | (R)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid; N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine; Valsartan,D; D-Valsartan; N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}valine; N-Pentanoyl-N-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-D-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine; DSSTox_CID_3735 |
| Molecular Formula | C24H29N5O3 |
| Molecular Weight | 435.52 |
| Purity | 98 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 684.9±65.0 °C at 760 mmHg |
| Melting Point | 108-110°C |
| Appearance | solid |
| Storage Condition | Refrigerator |
| PubChem ID | 329751480 |
| SMILES | CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C |
| InChI | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m1/s1 |
| InChI Key | ACWBQPMHZXGDFX-JOCHJYFZSA-N |
| Transport Info | Product Name: Envarsatan |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 3(S)-HYDROXYMETHYLMORPHOLINE | 211053-50-8 | 2A-9073768 |
| (R)-1-((1-methylpyrrolidin-2-yl)methyl)piperidine | 155726-05-9 | 2A-9073774 |
| 3-TERT-BUTOXYCARBONYLAMINO-ISONICOTINICACID | 179024-65-8 | 2A-9073775 |
| (R)-1-Boc-2-Benzylpiperazine | 947684-78-8 | 2A-9073776 |
| (R)-5-Amino-piperidin-2-oneHCl | 1003021-01-9 | 2A-9073778 |
| (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one | 149524-42-5 | 2A-9073781 |
| (R)-3-Fluoropyrrolidine | 136725-54-7 | 2A-9073784 |
| (R)-N-Boc-3-Methylmorpholine | 1022093-98-6 | 2A-9073785 |
| 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridinehydrochloride | 1121057-75-7 | 2A-9073787 |
| (R)-Piperidine-1,3-dicarboxylicacid1-benzylester | 160706-62-7 | 2A-9073789 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA